To the Editor We read with interest the article by Fenton et al1 published in a recent issue of JAMA Internal Medicine that reported overtreatment of osteoporosis through a retrospective cohort study that included 6150 women aged 40 to 85 years. The authors defined the treatment criteria of osteoporosis should be the T score less than −2.5 at main site. According to their standard, two-thirds of new osteoporosis drug prescriptions could be potentially inappropriate. However, we have some concerns about this study.
Xu F, Yuan L. Osteoporosis Overtreatment—A Clinical Problem That Needs to Be Discussed. JAMA Intern Med. 2016;176(7):1033-1034. doi:10.1001/jamainternmed.2016.2731